These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 34592752)

  • 61. Peripheral T-cell lymphomas with a follicular growth pattern are derived from follicular helper T cells (TFH) and may show overlapping features with angioimmunoblastic T-cell lymphomas.
    Huang Y; Moreau A; Dupuis J; Streubel B; Petit B; Le Gouill S; Martin-Garcia N; Copie-Bergman C; Gaillard F; Qubaja M; Fabiani B; Roncador G; Haioun C; Delfau-Larue MH; Marafioti T; Chott A; Gaulard P
    Am J Surg Pathol; 2009 May; 33(5):682-90. PubMed ID: 19295409
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Integration of transcriptional and mutational data simplifies the stratification of peripheral T-cell lymphoma.
    Maura F; Agnelli L; Leongamornlert D; Bolli N; Chan WC; Dodero A; Carniti C; Heavican TB; Pellegrinelli A; Pruneri G; Butler A; Bhosle SG; Chiappella A; Di Rocco A; Zinzani PL; Zaja F; Piva R; Inghirami G; Wang W; Palomero T; Iqbal J; Neri A; Campbell PJ; Corradini P
    Am J Hematol; 2019 Jun; 94(6):628-634. PubMed ID: 30829413
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Peripheral T-cell lymphomas of follicular T-helper cell derivation with Hodgkin/Reed-Sternberg cells of B-cell lineage: both EBV-positive and EBV-negative variants exist.
    Nicolae A; Pittaluga S; Venkataraman G; Vijnovich-Baron A; Xi L; Raffeld M; Jaffe ES
    Am J Surg Pathol; 2013 Jun; 37(6):816-26. PubMed ID: 23598959
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A Clinicopathologic Study of Lennert Lymphoma and Possible Prognostic Factors: The Importance of Follicular Helper T-cell Markers and the Association With Angioimmunoblastic T-cell Lymphoma.
    Kurita D; Miyoshi H; Yoshida N; Sasaki Y; Kato S; Niino D; Sugita Y; Hatta Y; Takei M; Makishima M; Ohshima K
    Am J Surg Pathol; 2016 Sep; 40(9):1249-60. PubMed ID: 27428734
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Analysis of prognostic factors in peripheral T-cell lymphoma: prognostic value of serum albumin and mediastinal lymphadenopathy.
    Chihara D; Oki Y; Ine S; Yamamoto K; Kato H; Taji H; Kagami Y; Yatabe Y; Nakamura S; Morishima Y
    Leuk Lymphoma; 2009 Dec; 50(12):1999-2004. PubMed ID: 19860627
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The gene expression profile and cell of origin of canine peripheral T-cell lymphoma.
    Owens E; Harris L; Harris A; Yoshimoto J; Burnett R; Avery A
    BMC Cancer; 2024 Jan; 24(1):18. PubMed ID: 38166662
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Epstein-Barr virus-positive nodal peripheral T cell lymphomas: clinicopathologic and gene expression profiling study.
    Ha SY; Sung J; Ju H; Karube K; Kim SJ; Kim WS; Seto M; Ko YH
    Pathol Res Pract; 2013 Jul; 209(7):448-54. PubMed ID: 23735590
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The Expressions of P53, Bcl-2, and P-Glycoprotein and Prognostic Impact in Patients with Peripheral T-Cell Lymphoma (PTCL).
    Julamanee J; Kayasut K; Lekhakula A
    J Med Assoc Thai; 2015 Oct; 98(10):950-6. PubMed ID: 26638586
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Molecular pathogenesis of peripheral T-cell lymphoma (1): angioimmunoblastic T-cell lymphoma, peripheral T-cell lymphoma, not otherwise specified and anaplastic large cell lymphoma].
    Couronné L; Bastard C; Gaulard P; Hermine O; Bernard O
    Med Sci (Paris); 2015 Oct; 31(10):841-52. PubMed ID: 26481023
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Molecular heterogeneity in peripheral T-cell lymphoma, not otherwise specified revealed by comprehensive genetic profiling.
    Watatani Y; Sato Y; Miyoshi H; Sakamoto K; Nishida K; Gion Y; Nagata Y; Shiraishi Y; Chiba K; Tanaka H; Zhao L; Ochi Y; Takeuchi Y; Takeda J; Ueno H; Kogure Y; Shiozawa Y; Kakiuchi N; Yoshizato T; Nakagawa MM; Nanya Y; Yoshida K; Makishima H; Sanada M; Sakata-Yanagimoto M; Chiba S; Matsuoka R; Noguchi M; Hiramoto N; Ishikawa T; Kitagawa J; Nakamura N; Tsurumi H; Miyazaki T; Kito Y; Miyano S; Shimoda K; Takeuchi K; Ohshima K; Yoshino T; Ogawa S; Kataoka K
    Leukemia; 2019 Dec; 33(12):2867-2883. PubMed ID: 31092896
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Risk factors and timing of autologous stem cell transplantation for patients with peripheral T-cell lymphoma.
    Yamasaki S; Chihara D; Kim SW; Kawata T; Mizuta S; Ago H; Chou T; Yamane T; Uchiyama H; Oyake T; Miura K; Saito B; Taji H; Nakamae H; Miyamoto T; Fukuda T; Kanda J; Atsuta Y; Suzuki R
    Int J Hematol; 2019 Feb; 109(2):175-186. PubMed ID: 30430419
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The aggressive peripheral T-cell lymphomas: 2015.
    Armitage JO
    Am J Hematol; 2015 Jul; 90(7):665-73. PubMed ID: 26031230
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Clinicopathological characterization of follicular helper T-cell-derived peripheral T-cell lymphoma involving Waldeyer's ring.
    Wang J; Tang W; Zhang W; Wang J; Chen F; Zhong L; Chen Y; Chen G
    Virchows Arch; 2021 Aug; 479(2):355-363. PubMed ID: 33650043
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Angioimmunoblastic T-cell lymphoma: more than a disease of T follicular helper cells.
    Lemonnier F; Mak TW
    J Pathol; 2017 Aug; 242(4):387-390. PubMed ID: 28543514
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Proteomic profiling identifies outcome-predictive markers in patients with peripheral T-cell lymphoma, not otherwise specified.
    Ludvigsen M; Bjerregård Pedersen M; Lystlund Lauridsen K; Svenstrup Poulsen T; Hamilton-Dutoit SJ; Besenbacher S; Bendix K; Møller MB; Nørgaard P; d'Amore F; Honoré B
    Blood Adv; 2018 Oct; 2(19):2533-2542. PubMed ID: 30291111
    [TBL] [Abstract][Full Text] [Related]  

  • 76. How I manage peripheral T-cell lymphoma, not otherwise specified and angioimmunoblastic T-cell lymphoma: current practice and a glimpse into the future.
    Schmitz N; de Leval L
    Br J Haematol; 2017 Mar; 176(6):851-866. PubMed ID: 27982416
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Follicular helper T-cell lymphomas: disease spectrum, relationship with clonal hematopoiesis, and mimics. A report of the 2022 EA4HP/SH lymphoma workshop.
    Ondrejka SL; Amador C; Climent F; Ng SB; Soma L; Zamo A; Dirnhofer S; Quintanilla-Martinez L; Wotherspoon A; Leoncini L; de Leval L
    Virchows Arch; 2023 Sep; 483(3):349-365. PubMed ID: 37500795
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Angioimmunoblastic T-Cell Lymphoma.
    Yabe M; Dogan A; Horwitz SM; Moskowitz AJ
    Cancer Treat Res; 2019; 176():99-126. PubMed ID: 30596215
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The survival outcome of patients with relapsed/refractory peripheral T-cell lymphoma-not otherwise specified and angioimmunoblastic T-cell lymphoma.
    Chihara D; Fanale MA; Miranda RN; Noorani M; Westin JR; Nastoupil LJ; Hagemeister FB; Fayad LE; Romaguera JE; Samaniego F; Turturro F; Lee HJ; Neelapu SS; Rodriguez MA; Wang M; Fowler NH; Davis RE; Medeiros LJ; Hosing C; Nieto YL; Oki Y
    Br J Haematol; 2017 Mar; 176(5):750-758. PubMed ID: 27983760
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Genomics of Peripheral T-Cell Lymphoma and Its Implications for Personalized Medicine.
    Zhang Y; Lee D; Brimer T; Hussaini M; Sokol L
    Front Oncol; 2020; 10():898. PubMed ID: 32637355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.